loading page

Oral mucositis in children with hematologic tumors undergoing chemotherapy: A case series
  • +5
  • Fabio dos Santos,
  • Paula Maria Bezerra,
  • Nayara Pereira Limão,
  • Ynnaiana Santana,
  • Isabella Ribeiro,
  • Paulo Rogério Ferreti Bonan,
  • Simone Sousa,
  • Ana Maria Gondim Valença
Fabio dos Santos
UFPB

Corresponding Author:[email protected]

Author Profile
Paula Maria Bezerra
UFPB
Author Profile
Nayara Pereira Limão
Universidade Federal da Paraiba Centro de Ciencias da Saude
Author Profile
Ynnaiana Santana
UFPB
Author Profile
Isabella Ribeiro
Universidade Federal da Paraiba Centro de Ciencias da Saude
Author Profile
Paulo Rogério Ferreti Bonan
Universidade Federal da Paraiba Centro de Ciencias da Saude
Author Profile
Simone Sousa
UFPB
Author Profile
Ana Maria Gondim Valença
Universidade Federal da Paraiba Centro de Ciencias da Saude
Author Profile

Abstract

Oral mucositis (OM) is the most common local adverse event of chemotherapy treatment and leads to a debilitating condition from the patient’s perspective. The aim of this study is to report nine cases of severe OM over 10 weeks after initiating chemotherapy in pediatric patients with leukemia. All patients showed changes in normality of hematological data in most week. The most used chemotherapeutic agents were aracytin, etoposide and methotrexate. Saliva and lips were the most affected items. Well-designed observational studies are needed to better understand the risk factors for developing severe OM.